{
    "clinical_study": {
        "@rank": "38506", 
        "arm_group": [
            {
                "arm_group_label": "methylphenidate hydrochloride", 
                "arm_group_type": "Experimental", 
                "description": "The study will include two sessions which will be conducted at the same time of the day, one week apart from each other. Each session will last approximately 6 hours. In each session subjects will be exposed to baseline experimental pain models and auditory tests. Then they will receive either one MP SR 20 mg tablet or an identical looking placebo."
            }, 
            {
                "arm_group_label": "Sugar pill", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The study will include two sessions which will be conducted at the same time of the day, one week apart from each other. Each session will last approximately 6 hours. In each session subjects will be exposed to baseline experimental pain models and auditory tests. Then they will receive either one MP SR 20 mg tablet or an identical looking placebo."
            }
        ], 
        "brief_summary": {
            "textblock": "1. To examine whether Ritalin has analgesic properties in healthy subjects.\n\n        2. To examine if Ritalin analgesic effect is a pain specific phenomenon or a part of a\n           broader, non-specific effect on high mental functions."
        }, 
        "brief_title": "The Effect of Ritalin (Methylphenidate Hydrochloride) on Pain and Auditory Sensitivity: an Exploratory Double-blind Randomized Controlled Trial on Healthy Subjects", 
        "condition": "Pharmacological Action (PA)", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male subjects between the ages of 20 to 40\n\n          -  Healthy subjects without known disease and without any chronic pain\n\n          -  Subjects without known cognitive problems, which can understand the research and its\n             goals\n\n          -  Subjects who are not taking any medications\n\n          -  Subjects without hearing problems\n\n          -  Subjects without attention deficit disorder (ADHD) problems\n\n        Exclusion Criteria:\n\n          -  Subjects who are known to suffer from any disease or any chronic pain\n\n          -  Subjects taking psychotropic drugs (except Ritalin) or any analgesics\n\n          -  Subjects who have any contradictions for ritalin administration\n\n          -  subjects with suspected cognitive disability"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914822", 
            "org_study_id": "275-13-RMB", 
            "secondary_id": "Ritalin version 5"
        }, 
        "intervention": [
            {
                "arm_group_label": "methylphenidate hydrochloride", 
                "intervention_name": "methylphenidate hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sugar pill", 
                "intervention_name": "Sugar pill (placebo)", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methylphenidate"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Ritalin", 
            "methylphenidate hydrochloride", 
            "experimental pain"
        ], 
        "lastchanged_date": "February 19, 2014", 
        "location": {
            "contact": {
                "email": "e_eisenberg@rambam.health.gov.il", 
                "last_name": "Elon Eisenberg, MD", 
                "phone": "972 4 8542880"
            }, 
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel", 
                    "zip": "31096"
                }, 
                "name": "Rambam Healthcare Campus"
            }, 
            "investigator": {
                "last_name": "Elon Eisenberg, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Ritalin (Methylphenidate Hydrochloride) on Pain and Auditory Sensitivity: an Exploratory Double-blind Randomized Controlled Trial on Healthy Subjects", 
        "overall_contact": {
            "email": "e_eisenberg@rambam.health.gov.il", 
            "last_name": "Elon Eisenberg, MD", 
            "phone": "972 4 8542880"
        }, 
        "overall_official": {
            "affiliation": "Rambam Helthcare Campus, Haifa, Israel 31096", 
            "last_name": "Elon Eisenberg, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Experimental pain intensity measured on a visual analogue scale (0-100)", 
            "safety_issue": "No", 
            "time_frame": "4 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914822"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rambam Health Care Campus", 
            "investigator_full_name": "Eisenberg Elon MD", 
            "investigator_title": "Director, Pain research Unit", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "effect of Ritalin on auditory sensitivity, measured by the response to different auditory stimulations", 
                "safety_issue": "No", 
                "time_frame": "4 hours"
            }, 
            {
                "measure": "pain intensity (NPS 0-100) in response to thermal stimuli and the measures of the auditory tests.", 
                "safety_issue": "No", 
                "time_frame": "4 hours"
            }
        ], 
        "source": "Rambam Health Care Campus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rambam Health Care Campus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}